Patents by Inventor Anne MacPherson

Anne MacPherson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075174
    Abstract: A method of decontaminating a surface includes exposing the surface to germicidal UV light emitted by at least one germicidal UV light source, preferably a light emitting diode (LED), for a continuous exposure period of between 0.05 seconds and 2 seconds; discontinuing the exposure of the surface to the germicidal UV light for a continuous rest period of between 30 seconds and 120 seconds; and repeating steps a. and b. for a total of at least 3 cycles.
    Type: Application
    Filed: January 27, 2022
    Publication date: March 7, 2024
    Applicant: U TECHNOLOGY CORPORATION
    Inventors: MARK LEFSRUD, REBECCA MARTINEZ, ANNE SOPHIE RUFYIKIRI, SARAH MACPHERSON, BO-SEN WU
  • Patent number: 8669050
    Abstract: The present invention relates generally to novel nucleic acid molecules, the levels and/or patterns of expression of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm and to derivatives, homologues or analogues of said molecules. More particularly, the present invention is directed to novel nucleic acid molecules, the levels of expression of which are indicative of the onset and/or progression of a gastrointestinal tract neoplasm, such as an adenoma, and to derivatives, homologues or analogues of said molecules. The present invention is further directed to isolated proteins encoded thereby and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of prophylactic, therapeutic and/or diagnostic applications including, but not limited to, those relating to the diagnosis and/or treatment of colorectal neoplasms such as colorectal adenomas.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: March 11, 2014
    Assignee: Clinical Genomics Pty. Ltd.
    Inventors: Robert James, Julianne Henry, Jan Kazenwadel, Nick Van Host Pellekaan, Anne MacPherson, Susan O'Connor
  • Publication number: 20050053967
    Abstract: The present invention relates generally to novel nucleic acid molecules, the levels and/or patterns of expression of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm and to derivatives, homologues or analogues of said molecules. More particularly, the present invention is directed to novel nucleic acid molecules, the levels of expression of which are indicative of the onset and/or progression of a gastrointestinal tract neoplasm, such as an adenoma, and to derivatives, homologues or analogues of said molecules. The present invention is further directed to isolated proteins encoded thereby and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of prophylactic, therapeutic and/or diagnostic applications including, but not limited to, those relating to the diagnosis and/or treatment of colorectal neoplasms such as colorectal adenomas.
    Type: Application
    Filed: March 12, 2004
    Publication date: March 10, 2005
    Applicant: MediMolecular Pty Ltd.
    Inventors: Robert James, Julianne Henry, Jan Kazenwadel, Nick Pellekaan, Anne MacPherson, Susan O'Connor